• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

量化扩大年龄组脊髓灰质炎根除运动的影响。

Quantifying the impact of expanded age group campaigns for polio eradication.

作者信息

Wagner Bradley G, Behrend Matthew R, Klein Daniel J, Upfill-Brown Alexander M, Eckhoff Philip A, Hu Hao

机构信息

Institute for Disease Modeling, Bellevue, Washington, United States of America.

出版信息

PLoS One. 2014 Dec 1;9(12):e113538. doi: 10.1371/journal.pone.0113538. eCollection 2014.

DOI:10.1371/journal.pone.0113538
PMID:25437014
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4249973/
Abstract

A priority of the Global Polio Eradication Initiative (GPEI) 2013-2018 strategic plan is to evaluate the potential impact on polio eradication resulting from expanding one or more Supplementary Immunization Activities (SIAs) to children beyond age five-years in polio endemic countries. It has been hypothesized that such expanded age group (EAG) campaigns could accelerate polio eradication by eliminating immunity gaps in older children that may have resulted from past periods of low vaccination coverage. Using an individual-based mathematical model, we quantified the impact of EAG campaigns in terms of probability of elimination, reduction in polio transmission and age stratified immunity levels. The model was specifically calibrated to seroprevalence data from a polio-endemic region: Zaria, Nigeria. We compared the impact of EAG campaigns, which depend only on age, to more targeted interventions which focus on reaching missed populations. We found that EAG campaigns would not significantly improve prospects for polio eradication; the probability of elimination increased by 8% (from 24% at baseline to 32%) when expanding three annual SIAs to 5-14 year old children and by 18% when expanding all six annual SIAs. In contrast, expanding only two of the annual SIAs to target hard-to-reach populations at modest vaccination coverage-representing less than one tenth of additional vaccinations required for the six SIA EAG scenario-increased the probability of elimination by 55%. Implementation of EAG campaigns in polio endemic regions would not improve prospects for eradication. In endemic areas, vaccination campaigns which do not target missed populations will not benefit polio eradication efforts.

摘要

全球消灭脊髓灰质炎行动(GPEI)2013 - 2018年战略计划的一项重点是评估在脊髓灰质炎流行国家将一项或多项补充免疫活动(SIA)扩展至五岁以上儿童对消灭脊髓灰质炎可能产生的影响。据推测,这种扩大年龄组(EAG)活动可通过消除大龄儿童中因过去疫苗接种覆盖率低而可能产生的免疫空白来加速消灭脊髓灰质炎。我们使用基于个体的数学模型,从消灭概率、脊髓灰质炎传播减少情况以及按年龄分层的免疫水平方面,对EAG活动的影响进行了量化。该模型专门根据脊髓灰质炎流行地区——尼日利亚扎里亚的血清学流行率数据进行了校准。我们将仅取决于年龄的EAG活动的影响与更具针对性的、侧重于覆盖未接种人群的干预措施的影响进行了比较。我们发现,EAG活动不会显著改善消灭脊髓灰质炎的前景;将三项年度SIA扩展至5 - 14岁儿童时,消灭概率提高了8%(从基线时的24%增至32%),将所有六项年度SIA扩展时,消灭概率提高了18%。相比之下,仅将两项年度SIA扩展至疫苗接种覆盖率较低的难以到达人群(占六项SIA EAG方案所需额外接种疫苗的不到十分之一),消灭概率提高了55%。在脊髓灰质炎流行地区开展EAG活动不会改善消灭工作的前景。在流行地区,不针对未接种人群的疫苗接种活动对消灭脊髓灰质炎的努力没有益处。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a80e/4249973/7b1e29d50d88/pone.0113538.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a80e/4249973/9e5cdfb4a233/pone.0113538.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a80e/4249973/c70b3e97fa8a/pone.0113538.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a80e/4249973/d1098a49344a/pone.0113538.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a80e/4249973/b270478eccbe/pone.0113538.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a80e/4249973/39201aa7bacd/pone.0113538.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a80e/4249973/7b1e29d50d88/pone.0113538.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a80e/4249973/9e5cdfb4a233/pone.0113538.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a80e/4249973/c70b3e97fa8a/pone.0113538.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a80e/4249973/d1098a49344a/pone.0113538.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a80e/4249973/b270478eccbe/pone.0113538.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a80e/4249973/39201aa7bacd/pone.0113538.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a80e/4249973/7b1e29d50d88/pone.0113538.g006.jpg

相似文献

1
Quantifying the impact of expanded age group campaigns for polio eradication.量化扩大年龄组脊髓灰质炎根除运动的影响。
PLoS One. 2014 Dec 1;9(12):e113538. doi: 10.1371/journal.pone.0113538. eCollection 2014.
2
The potential impact of expanding target age groups for polio immunization campaigns.扩大脊髓灰质炎免疫接种运动目标年龄组的潜在影响。
BMC Infect Dis. 2014 Jan 29;14:45. doi: 10.1186/1471-2334-14-45.
3
The global polio eradication initiative: lessons learned and prospects for success.全球根除脊髓灰质炎倡议:经验教训与成功前景。
Vaccine. 2011 Dec 30;29 Suppl 4:D80-5. doi: 10.1016/j.vaccine.2011.10.005.
4
Demographics, epidemiology and the impact of vaccination campaigns in a measles-free world - Can elimination be maintained?无麻疹世界中的人口统计学、流行病学及疫苗接种运动的影响——能否维持消除状态?
Vaccine. 2017 Mar 13;35(11):1488-1493. doi: 10.1016/j.vaccine.2017.02.008. Epub 2017 Feb 16.
5
Polio elimination in Nigeria: A review.尼日利亚的脊髓灰质炎消除工作:综述
Hum Vaccin Immunother. 2016 Mar 3;12(3):658-63. doi: 10.1080/21645515.2015.1088617.
6
Measuring polio immunity to plan immunization activities.测量脊髓灰质炎免疫力以规划免疫活动。
Vaccine. 2016 Nov 21;34(48):5946-5952. doi: 10.1016/j.vaccine.2016.10.017. Epub 2016 Oct 19.
7
Contribution of Global Polio Eradication Initiative-Funded Personnel to the Strengthening of Routine Immunization Programs in the 10 Focus Countries of the Polio Eradication and Endgame Strategic Plan.全球根除脊髓灰质炎行动资助人员对脊髓灰质炎根除和终局战略计划10个重点国家常规免疫规划强化工作的贡献
J Infect Dis. 2017 Jul 1;216(suppl_1):S244-S249. doi: 10.1093/infdis/jiw567.
8
Socioecological Challenges of Polio Supplementary Immunization Activities (SIAs) in the Asia-Pacific Region: A Systematic Review.亚太地区脊髓灰质炎补充免疫活动的社会生态学挑战:系统评价。
J Environ Public Health. 2023 Jan 28;2023:4801424. doi: 10.1155/2023/4801424. eCollection 2023.
9
Evolution of global polio eradication strategies: targets, vaccines, and supplemental immunization activities (SIAs).全球根除脊髓灰质炎策略的演变:目标、疫苗和补充免疫活动(SIA)。
Expert Rev Vaccines. 2024 Jan-Dec;23(1):597-613. doi: 10.1080/14760584.2024.2361060. Epub 2024 Jun 7.
10
An evaluation of community perspectives and contributing factors to missed children during an oral polio vaccination campaign--Katsina State, Nigeria.评估在口服脊髓灰质炎疫苗接种活动期间错过儿童的社区观点和促成因素——尼日利亚卡齐纳州。
J Infect Dis. 2014 Nov 1;210 Suppl 1:S131-5. doi: 10.1093/infdis/jiu288.

引用本文的文献

1
Assessing early detection ability through spatial arrangements in environmental surveillance for poliovirus: A simulation-based study.通过脊髓灰质炎病毒环境监测中的空间布局评估早期检测能力:一项基于模拟的研究
PLoS One. 2025 Jul 9;20(7):e0325789. doi: 10.1371/journal.pone.0325789. eCollection 2025.
2
Vaccination strategies against wild poliomyelitis in polio-free settings: outbreak risk modelling study and cost-effectiveness analysis.无脊髓灰质炎地区针对野生脊髓灰质炎的疫苗接种策略:疫情风险建模研究与成本效益分析
BMJ Glob Health. 2025 Mar 22;10(3):e016013. doi: 10.1136/bmjgh-2024-016013.
3
Modelling the spread of serotype-2 vaccine derived-poliovirus outbreak in Pakistan and Afghanistan to inform outbreak control strategies in the context of the COVID-19 pandemic.

本文引用的文献

1
The role of older children and adults in wild poliovirus transmission.大龄儿童和成人在野生脊灰病毒传播中的作用。
Proc Natl Acad Sci U S A. 2014 Jul 22;111(29):10604-9. doi: 10.1073/pnas.1323688111. Epub 2014 Jul 7.
2
A quantitative survey of the literature on poliovirus infection and immunity.关于脊髓灰质炎病毒感染和免疫的文献定量调查。
Int J Infect Dis. 2014 Jan;18:4-13. doi: 10.1016/j.ijid.2013.09.005. Epub 2013 Oct 22.
3
Public health: Polio's moving target.公共卫生:不断变化的脊髓灰质炎目标。
建立模型以模拟巴基斯坦和阿富汗 2 型疫苗衍生脊髓灰质炎病毒暴发的传播情况,以在 COVID-19 大流行背景下为暴发控制策略提供信息。
Vaccine. 2023 Apr 6;41 Suppl 1:A93-A104. doi: 10.1016/j.vaccine.2021.09.037. Epub 2021 Sep 25.
4
Review of poliovirus modeling performed from 2000 to 2019 to support global polio eradication.回顾 2000 年至 2019 年期间为支持全球根除脊髓灰质炎而进行的脊髓灰质炎病毒建模。
Expert Rev Vaccines. 2020 Jul;19(7):661-686. doi: 10.1080/14760584.2020.1791093. Epub 2020 Aug 1.
5
Costs and Benefits of Including Inactivated in Addition to Oral Poliovirus Vaccine in Outbreak Response After Cessation of Oral Poliovirus Vaccine Use.在停止使用口服脊髓灰质炎疫苗后,在疫情应对中除口服脊髓灰质炎疫苗外加入灭活脊髓灰质炎疫苗的成本与效益
MDM Policy Pract. 2017 Mar 1;2(1):2381468317697002. doi: 10.1177/2381468317697002. eCollection 2017 Jan-Jun.
6
Evaluation of Proactive and Reactive Strategies for Polio Eradication Activities in Pakistan and Afghanistan.评估巴基斯坦和阿富汗消灭脊灰炎活动中的主动和被动策略。
Risk Anal. 2019 Feb;39(2):389-401. doi: 10.1111/risa.13194. Epub 2018 Sep 21.
7
Quantitative Microbial Risk Assessment and Infectious Disease Transmission Modeling of Waterborne Enteric Pathogens.基于定量微生物风险评估和水传播肠道病原体传染病传播模型的研究
Curr Environ Health Rep. 2018 Jun;5(2):293-304. doi: 10.1007/s40572-018-0196-x.
8
Modeling Poliovirus Transmission in Pakistan and Afghanistan to Inform Vaccination Strategies in Undervaccinated Subpopulations.建模巴基斯坦和阿富汗的脊髓灰质炎病毒传播,以制定在疫苗接种不足的亚人群中疫苗接种策略。
Risk Anal. 2018 Aug;38(8):1701-1717. doi: 10.1111/risa.12962. Epub 2018 Jan 3.
9
Lessons from a decade of individual-based models for infectious disease transmission: a systematic review (2006-2015).基于个体的传染病传播模型十年经验教训:一项系统综述(2006 - 2015年)
BMC Infect Dis. 2017 Sep 11;17(1):612. doi: 10.1186/s12879-017-2699-8.
10
Lessons From the Polio Endgame: Overcoming the Failure to Vaccinate and the Role of Subpopulations in Maintaining Transmission.脊髓灰质炎终结阶段的经验教训:克服疫苗接种失败以及亚人群在维持传播中的作用
J Infect Dis. 2017 Jul 1;216(suppl_1):S176-S182. doi: 10.1093/infdis/jix108.
Nature. 2013 Apr 18;496(7445):290-2. doi: 10.1038/496290a.
4
Successes and shortcomings of polio eradication: a transmission modeling analysis.脊髓灰质炎根除的成败:传播建模分析。
Am J Epidemiol. 2013 Jun 1;177(11):1236-45. doi: 10.1093/aje/kws378. Epub 2013 Apr 16.
5
Seroprevalence of poliovirus antibodies amongst children in Zaria, Northern Nigeria.尼日利亚北部扎里亚地区儿童脊髓灰质炎病毒抗体的血清流行率。
Vaccine. 2012 Nov 6;30(48):6759-65. doi: 10.1016/j.vaccine.2012.09.023. Epub 2012 Sep 20.
6
Estimating and Projecting Trends in HIV/AIDS Generalized Epidemics Using Incremental Mixture Importance Sampling.使用增量混合重要性抽样估计和预测艾滋病毒/艾滋病广泛流行趋势
Biometrics. 2010 Dec;66(4):1162-73. doi: 10.1111/j.1541-0420.2010.01399.x.
7
Estimating the extent of vaccine-derived poliovirus infection.估算疫苗衍生脊髓灰质炎病毒感染的范围。
PLoS One. 2008;3(10):e3433. doi: 10.1371/journal.pone.0003433. Epub 2008 Oct 29.
8
Long-lasting poliovirus-neutralizing antibodies among Argentinean population immunized with four or five oral polio vaccine doses 1 month to 19 years previously.1个月至19年前接受过四剂或五剂口服脊髓灰质炎疫苗免疫的阿根廷人群中存在持久的脊髓灰质炎病毒中和抗体。
Viral Immunol. 2007 Spring;20(1):3-10. doi: 10.1089/vim.2006.0071.
9
Vaccination against poliomyelitis with live virus vaccines. 7. Effect of previous Salk vaccination on virus excretion.使用活病毒疫苗进行脊髓灰质炎疫苗接种。7. 先前接种索尔克疫苗对病毒排泄的影响。
Br Med J. 1961 Jul 29;2(5247):266-9. doi: 10.1136/bmj.2.5247.266.
10
The degree and duration of poliomyelitis virus excretion among vaccinated household contacts of clinical cases of poliomyelitis.脊髓灰质炎临床病例的接种疫苗家庭接触者中脊髓灰质炎病毒排泄的程度和持续时间。
Pediatrics. 1958 Jul;22(1, Part 1):33-40.